Table 1.

Dosing schedule for AFM13 and pembrolizumab as combination therapy

	AFM13 dose levels (mg/kg)			Pembrolizumab (mg)
	Weeks 2 and 3	Weeks 4-9	Weeks 10, 13, 16, 19, 22, 25	Weeks 1-52 Q3W*
Cohort 1	0.1 × 3	0.5	0.5	200
Cohort 2	0.5 × 3	1.5	1.5	200
Cohort 3	3.0 × 3	7.0	7.0	200

Q3W, once every 3 weeks.

^*Until disease progression, unacceptable toxicity, cessation of treatment because of complete response (at investigator’s discretion) or 52 weeks of treatment, whichever occurred first.